Literature DB >> 19734244

Longitudinal study of stressful life events and daily stressors among adolescents at high risk for psychotic disorders.

Kevin D Tessner1, Vijay Mittal, Elaine F Walker.   

Abstract

Psychosocial stress preceding the onset or recurrence of psychotic symptoms has been identified in patients with schizophrenia; yet there is limited understanding of the effects of stress in typically developing adolescents or those who show behavioral signs of risk for schizophrenia spectrum disorders. This study examined the developmental course of symptom progression as a function of stressful life events and daily hassles in adolescents with schizotypal personality disorder (SPD), other personality disorders, or no Axis II disorder. In this prospective longitudinal study, life events and daily stressors were assessed in adolescents aged 12 to 18 years. Results revealed that adolescents with SPD and other personality disorders reported significantly greater total, independent, and undesirable life events than individuals with no Axis II disorders. Youth with SPD report daily hassles to cause more distress compared to peers. Correlational analyses and hierarchal linear regression was used to evaluate the relationship of life events and daily stressors with psychiatric symptoms measured concurrently and 1 year later. Across diagnostic groups, the incidence of independent and undesirable life events were associated with current prodromal symptoms, while the frequency of daily stressors predicted a significant increment in positive, but not negative, prodromal symptoms over time. Therefore, adolescents who report greater daily stressors exhibit an increase in prodromal symptoms over a 1 year period. Psychosocial stress has been implicated in the etiology of schizophrenia, and these findings suggest the importance of life events and daily hassles as potential risk factors in the onset of psychotic symptoms during adolescence.

Entities:  

Mesh:

Year:  2009        PMID: 19734244      PMCID: PMC3044629          DOI: 10.1093/schbul/sbp087

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  45 in total

Review 1.  The evolution of life events research in psychiatry.

Authors:  E S Paykel
Journal:  J Affect Disord       Date:  2001-02       Impact factor: 4.839

Review 2.  Life events, stress and depression: a review of recent findings.

Authors:  Christopher Tennant
Journal:  Aust N Z J Psychiatry       Date:  2002-04       Impact factor: 5.744

3.  Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: Inverse relationships during postadolescent brain maturation.

Authors:  E R Sowell; P M Thompson; K D Tessner; A W Toga
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

4.  Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia.

Authors:  P Miller; S M Lawrie; A Hodges; R Clafferty; R Cosway; E C Johnstone
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2001-07       Impact factor: 4.328

Review 5.  Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model.

Authors:  J M Cyranowski; E Frank; E Young; M K Shear
Journal:  Arch Gen Psychiatry       Date:  2000-01

6.  Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents.

Authors:  I M Goodyer; J Herbert; A Tamplin; P M Altham
Journal:  Br J Psychiatry       Date:  2000-12       Impact factor: 9.319

7.  Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna Lifshey Rosen; Lubna Somjee; Philip J Markovich; Kelly Stein; Scott W Woods
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

8.  First-episode major depression in adolescents. Affective, cognitive and endocrine characteristics of risk status and predictors of onset.

Authors:  I M Goodyer; J Herbert; A Tamplin; P M Altham
Journal:  Br J Psychiatry       Date:  2000-02       Impact factor: 9.319

9.  Prevalence and incidence of schizophrenia spectrum disorders: implications for prevention.

Authors:  A Jablensky
Journal:  Aust N Z J Psychiatry       Date:  2000-11       Impact factor: 5.744

10.  The role of life events in onset and recurrent episodes of schizophrenia and schizoaffective disorder.

Authors:  M R Castine; J H Meador-Woodruff; G W Dalack
Journal:  J Psychiatr Res       Date:  1998 Sep-Oct       Impact factor: 4.791

View more
  41 in total

1.  The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis.

Authors:  Danielle M Moskow; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Robert Heinssen; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Tyrone D Cannon; Scott W Woods; Elaine F Walker
Journal:  Schizophr Res       Date:  2016-02-20       Impact factor: 4.939

2.  Daily hassles, mother-child relationship, and behavior problems in Muslim Arab American adolescents in immigrant families.

Authors:  Karen J Aroian; Thomas N Templin; Edythe S Hough
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2016-04-07

3.  Cortisol Reactivity to Stress and Its Association With White Matter Integrity in Adults With Schizophrenia.

Authors:  Katie L Nugent; Joshua Chiappelli; Hemalatha Sampath; Laura M Rowland; Kavita Thangavelu; Beshaun Davis; Xiaoming Du; Florian Muellerklein; Stacey Daughters; Peter Kochunov; L Elliot Hong
Journal:  Psychosom Med       Date:  2015-09       Impact factor: 4.312

Review 4.  Stress and neurodevelopmental processes in the emergence of psychosis.

Authors:  C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

5.  Fetal exposure to maternal stress and risk for schizophrenia spectrum disorders among offspring: Differential influences of fetal sex.

Authors:  Anna M Fineberg; Lauren M Ellman; Catherine A Schaefer; Seth D Maxwell; Ling Shen; Nashid H Chaudhury; Aundrea L Cook; Michaeline A Bresnahan; Ezra S Susser; Alan S Brown
Journal:  Psychiatry Res       Date:  2015-12-18       Impact factor: 3.222

6.  The role of vulnerability factors in individuals with an at-risk mental state of psychosis.

Authors:  Martina Papmeyer; Irène Würsch; Erich Studerus; Rolf-Dieter Stieglitz; Anita Riecher-Rössler
Journal:  Neuropsychiatr       Date:  2016-03-11

7.  Partial genetic deletion of neuregulin 1 modulates the effects of stress on sensorimotor gating, dendritic morphology, and HPA axis activity in adolescent mice.

Authors:  Tariq W Chohan; Aurelie A Boucher; Jarrah R Spencer; Mustafa S Kassem; Areeg A Hamdi; Tim Karl; Sandra Y Fok; Maxwell R Bennett; Jonathon C Arnold
Journal:  Schizophr Bull       Date:  2014-01-17       Impact factor: 9.306

8.  Disrupted glucocorticoid--Immune interactions during stress response in schizophrenia.

Authors:  Joshua Chiappelli; Qiaoyun Shi; Priyadurga Kodi; Anya Savransky; Peter Kochunov; Laura M Rowland; Katie L Nugent; L Elliot Hong
Journal:  Psychoneuroendocrinology       Date:  2015-09-12       Impact factor: 4.905

9.  Coping Strategies Mediate the Effect of Stressful Life Events on Schizotypal Traits and Psychotic Symptoms in 22q11.2 Deletion Syndrome.

Authors:  Marco Armando; Corrado Sandini; Maelle Chambaz; Marie Schaer; Maude Schneider; Stephan Eliez
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

10.  Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance.

Authors:  Joshua Chiappelli; Ana Pocivavsek; Katie L Nugent; Francesca M Notarangelo; Peter Kochunov; Laura M Rowland; Robert Schwarcz; L Elliot Hong
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.